Literature DB >> 6176319

Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.

E Lotzová, C A Savary, J U Gutterman, E M Hersh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6176319

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  15 in total

1.  Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.

Authors:  E Montserrat; N Villamor; A Urbano-Ispizua; J M Ribera; M Lozano; J L Vives-Corrons; C Rozman
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

Review 2.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.

Authors:  E Heidemann; J Weber; H Schmidt; U Reichmann
Journal:  Klin Wochenschr       Date:  1986-10-15

Review 4.  Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

Authors:  W H Cole; L Humphrey
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  Application of a new method for detecting the phenotype of target binding cells.

Authors:  R A Lindemann; J A Jenkins; R A Figlin; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Contradictory results in interferon research.

Authors:  G Sonnenfeld
Journal:  Surv Immunol Res       Date:  1984

Review 7.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients.

Authors:  C M Balch; A B Tilden; P A Dougherty; G A Cloud
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

9.  Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.

Authors:  M J Levin; F N Judson; L Eron; Y J Bryson; L Corey; M Murray; R R Scheer
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

10.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.